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We present a case of a young healthy female who developed recurrent cranial wound infections after a
traumatic injury, the etiologic organism ﬁnally identiﬁed as Mycoplasma hominis, an uncommon and
difﬁcult to isolate bacterium.
© 2021 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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Case
A 25-year old woman with no pertinent past medical history
presented intoxicated after a mechanical fall down a ﬂight of 15
stairs, and was found to have fractures of the left temporo-parietal
bone, with extension into the sinuses and acute epidural
hematoma with midline shift. She emergently underwent left
decompressive hemicraniectomy with duroplasty. Her initial postsurgical course was uncomplicated and she was discharged home
after 5 days.
She returned 1 month later with acute onset expressive aphasia.
At that time, she denied any fevers, chills, or night sweats, however
she reported clear ﬂuid drainage from her operative site. MRI with
and without contrast of the brain revealed a collection concerning
for subdural empyema at the site of the recent craniectomy. She
underwent a cranial wound washout and purulence was noted in
the subdural plane. Intraoperative specimens were negative on
Gram stain and grew low quantities (single or few colonies) of
normal skin ﬂora including Staphylococcus capitis, Cutibacterium
acnes (formerly Propionibacterium acnes) and Staphylococcus
epidermidis. Initially she was treated empirically with IV vancomycin, however she was transitioned to daptomycin after failure to
achieve therapeutic vancomycin troughs. Her aphasia resolved,
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and following her clinical improvement she was discharged on
post-operative day 4 with a plan to complete a 6-week course of
daptomycin.
Two days after her discharge, she was readmitted with fever,
weakness, recurrent aphasia, and edema at her recent surgical site.
MRI brain showed focal dehiscence along the temporal bone,
leptomeningeal enhancement along the left cerebral hemisphere
and a complex extra-axial ﬂuid collection along the left cerebral
convexity. There was no clinical or radiographic concern for
osteomyelitis in several CT and MRI images enhanced with
gadolinium. She was taken to the operating room urgently, and
a large amount of purulent drainage was noted in the epidural,
subdural, and subarachnoid spaces, without any adjacent bony
involvement. These ﬁndings were consistent with a complex
recurrent empyema and associated cerebritis. Daptomycin, cefepime and metronidazole were started empirically, however she
failed to improve and developed worsening aphasia and righthand weakness. Repeat MRI brain on post-operative day 4
demonstrated extensive leptomeningeal enhancement in the left
cerebral hemisphere consistent with meningitis as well as swelling
in the left frontoparietal region favoring cerebritis {Fig. 1}.
Continuous EEG monitoring was consistent with subclinical
seizures. Therefore, the patient was initiated on a short steroid
taper and anticonvulsant medications.
Gram stains from the intra operative specimens on this
readmission revealed white blood cells (WBC) but no organisms
and cultures showed no growth for the ﬁrst 3 days. On day 4,
possible pinpoint colonies were noted on anaerobic cultures (CDC
anaerobic agar), however Gram staining of the possible colonies
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an 8-week course of levoﬂoxacin 750 mg daily and doxycycline
100 mg every 12 h, and a 6 week course of daptomycin 10 mg/kg IV
via PICC line. A follow-up MRI brain 1 month after completion of
antibiotics revealed improvement in left cerebral edema and
leptomeningeal enhancement. Her symptoms completely resolved
and she completed her antibiotic regimen without complication.
She did well, and 11 months later (delay due to COVID-19
pandemic) she underwent left autologous cranioplasty. She was
seen 6 weeks post-operatively, and was doing well.
Discussion
This case highlights an otherwise healthy young woman who
presented on multiple occasions to the hospital with complications from a neurosurgery with an uncommon organism. Surgical
site infections are not uncommon, and typical organisms are
usually treated empirically until offending organisms are
identiﬁed. Appropriate antimicrobial therapy also takes into
account antibiotics penetration into abscesses in the cranial
nervous system (CNS). Studies have suggested that the bloodbrain barrier is different than the blood-CSF barrier and
antimicrobial levels in the abscess cavities do not always
correlate with the CSF levels [1]. Most common bacteria
associated with post-operative cranial infections include S.
aureus, followed by coagulase-negative staphylococci, C.acnes,
other gram negative bacteria, while no organisms are identiﬁed in
up to 8% of cases [2,3]. In the case of this patient, empiric therapies,
followed by pathogen-directed antibiotics after the ﬁrst infection
resulted in recurrent hospitalization.
The diagnostic conundrum was caused by the unique characteristics of Mycoplasma spp. These organisms are distinctive among
prokaryotes in that they do not have a cell wall (along with other
Mollicutes genera such as Ureaplasma). Not only does this make
them difﬁcult to treat (most empiric antibiotic regimens target cell
walls), it makes identiﬁcation by Gram staining impossible [4].
The presence of colonies which could not be observed with
Gram stain is what led the infectious disease and clinical
microbiology team to suspect Mycoplasma species as a likely
pathogen. Careful examination of microbiological cultures
revealed pinpoint growth on culture media which could have
been missed owing to their small size.
Prior to very recent phylogenetic updates [5] the genus
Mycoplasma included 118 species, of which M. genitalium (now
Mycoplasmoides genitalium), M. hominis (now Metamycoplasma
hominis) and M. pneumoniae (now Mycoplasmoides pneumoniae)
are clinically signiﬁcant. These bacteria have trilayered cell
membranes instead of a cell wall. They have the smallest genome
of known self-replicating organisms in the bacterial kingdom, with
limited biosynthetic capabilities which explains their parasitic or
saprophytic existence and fastidious growth requirements which
can complicate culture detection. Most mollicutes grow poorly or
not at all on standard microbiologic media, however, M. hominis
can grow on standard media (such as sheep’s blood trypticase soy
agar) and may be detected as early as 2–5 days [4]. These bacteria
can also be identiﬁed using polymerase chain reaction (PCR) and
DNA sequencing when routine cultures identify no growth, or to
conﬁrm the identiﬁcation of suspicious colonies as in our case.
Mycoplasmas are mucosally associated, rarely penetrating the
submucosa, except in cases of immunosuppression or instrumentation when they can enter the bloodstream and disseminate. The
natural habitat of M. hominis is the lower genital tracts of healthy
sexually active adults and usually does not cause disease while M.
genitalium is associated with non-gonococcal urethritis. M. hominis
has been associated with bacterial vaginosis, pelvic inﬂammatory
disease, and post-partum fever [6]. Infants can be colonized with
genital mycoplasmas during delivery, and cases of neonatal

Fig. 1. MRI Brain with and without contrast T2/FLAIR: Hyperintensity involving left
frontal gyrus concerning for focal cerebritis of the left anterior frontal lobe.

was negative. Colonies on CDC anaerobic agar from approximately
day 6 of culture are shown in Fig. 2. Upon further review of cultures
from the previous admission (collected 1 week prior), these
pinpoint colonies were also identiﬁed. These ﬁndings of fastidious
growth and inability to stain organisms with Gram stain raised
suspicions for Mycoplasma or Ureaplasma infection and she was
started on levoﬂoxacin and doxycycline. Culture growth morphologically consistent with Mycoplasma species was recovered from
all 9 intraoperative specimens (brain tissue, scalp, ﬂuid aspiration)
submitted for culture on readmission, and Mycoplasma hominis
was eventually identiﬁed using 16 s ribosomal DNA sequencing.
Susceptibility testing was requested, but unable to be obtained.
Her aphasia improved signiﬁcantly 2 days after starting
appropriate therapy. She was ultimately sent home to complete

Fig. 2. Pinpoint colonies visible on CDC anaerobic agar.
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meningitis, pneumonia and adverse pregnancy outcomes due to M.
hominis have been reported due to vertical transmission [7,8].
Extrapulmonary and extragenital infections caused by mycoplasmas are infrequently encountered, and M. hominis is the most
common culprit. There has been a recent rise in reported infections
due to mycoplasma, likely as a result of more widespread use of
PCR and DNA sequencing when routines cultures show no bacterial
growth [4]. There are several case reports of cranial infections due
to mycoplasmas. A healthy 29 year old male was found to have a
brain abscess 3 weeks after craniotomy for a subdural hematoma
due to a motor vehicle accident [9]. Brain empyema caused by M.
hominis was identiﬁed in another 43 year old alcoholic male after
sustaining a fall, when he developed signs of infection on day 5 of
his admission [10]. Delayed intracranial surgical site infections are
hypothesized to be disseminated possibly from iatrogenic genitourinary trauma, while infections presenting early on are potentially inoculated at the time of head trauma [11,12]. Meningitis as a
delayed presentation after neurosurgical intervention for intracerebral hemorrhage has also been reported [13]. There are well
documented cases of post-operative wound infections after open
heart surgeries, causing sternal wound infections, mediastinitis
and pericarditis. Other cases include sepsis syndromes, endocarditis and rarely abscesses [14]. These systemic infections are often
linked to immunosuppression related to impaired cell-mediated
immunity or hypogammaglobulinemia [15].
There have been no comparative studies to establish optimal
therapeutic strategies for treatment of genital mycoplasmas. Standardized methods with deﬁned MIC ranges have been published by
the Clinical and Laboratory Standards Institute (CLSI) [16]. Mycoplasmas are intrinsically resistant to all beta-lactams, sulfonamides,
trimethoprim and rifampin, with variable resistance of macrolides and
lincosamides. M. hominis is intrinsically resistant to erythromycin
and azithromycin owing to mutations in 23srRNA. Oral tetracyclines
have been the drugs of choice for urogenital infections due to M.
hominis, but resistance now occurs in 20–40 % of isolates and varies
geographically. Fluoroquinolones are usually active against all
mycoplasmas, however resistance in M. hominis has also been
reported [17–19]. This has led to recommendations of obtaining in
vitro susceptibility testing when M. hominis is recovered from
normally sterile sites, from immunocompromised hosts, and/or
from persons who have not responded to an initial treatment [17].
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Conclusion
This case illustrates the importance of considering M. hominis
infection in all well-documented systemic and local infections in
which properly collected specimens do not reveal a pathogen,
while in the absence of prior antibiotic treatment. In this example,
due to growth of skin ﬂora that could be potentially pathogenic, an
atypical infection was not initially suspected. On her second
presentation, failure to grow bacteria despite copious purulence
heightened the suspicion of an atypical infection and careful
examination by an experienced pathologist ultimately led to the
diagnosis. Review of literature also reveals a potential association
of M. hominis infections with head trauma as illustrated in this case
report, and has often caused delay in appropriate antimicrobials
due to difﬁculty in identiﬁcation of these bacteria.
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